エピソード

  • Pure Global's Guide to ANMAT: Why Your Choice of Medical Device Registration Holder in Argentina Can Make or Break Your LATAM Market Access.

    Pure Global's Guide to ANMAT: Why Your Choice of Medical Device Registration Holder in Argentina Can Make or Break Your LATAM Market Access.
    2025/08/24
    In this episode of LATAM MedTech Insights, we dive into one of the most critical and often misunderstood aspects of entering the Argentine medical device market: the role of the local registration holder. While ANMAT's requirement for a local representative seems straightforward, the legal implications of who you choose can have massive consequences for your business. We explore why appointing your commercial distributor as your registration holder can be a high-risk strategy. This episode uncovers how this common practice can lead to a complete loss of market access, forcing companies to restart the costly and time-consuming registration process from zero. We detail the strategic advantages of separating your regulatory representation from your commercial partnerships to ensure business continuity and protect your investment. **What You'll Learn:** - Why is ANMAT's requirement for a local registration holder more than just an administrative step? - What are the hidden risks of appointing your distributor as your registration holder in Argentina? - Who legally owns your medical device registration in Argentina, and why does it matter? - If you split with your local partner, what happens to your hard-won market approval? - How can an independent representative provide business continuity and control over your assets? - Is this registration ownership model unique to Argentina, or is it a common theme in LATAM? - What key criteria should you use when selecting a local registration holder in Argentina? At Pure Global, we specialize in providing independent, expert local representation to safeguard your market access. We act as your registration holder across Latin America, ensuring you maintain full control over your assets while having the flexibility to build the best commercial strategy. Ready to secure and streamline your entry into Argentina? Contact us at info@pureglobal.com or visit https://pureglobal.com/ for a strategic consultation.
    続きを読む 一部表示
    10 分
  • Navigating MedTech in LATAM: A Pure Global Deep Dive into Medical Device Classification Rules in Brazil, Mexico, and Colombia

    Navigating MedTech in LATAM: A Pure Global Deep Dive into Medical Device Classification Rules in Brazil, Mexico, and Colombia
    2025/08/23
    In this episode of LATAM MedTech Insights, we demystify the complex web of medical device classification rules across Latin America's key markets. While most countries use a risk-based system, the specific requirements of agencies like Brazil's ANVISA, Mexico's COFEPRIS, and Colombia's INVIMA present unique challenges that can derail market entry for unprepared companies. We explore how seemingly minor details in documentation, translation, and local procedural norms can lead to major delays. This episode provides essential insights for any MedTech company looking to expand into this dynamic but demanding region, moving beyond the regulations to discuss real-world examples and common pitfalls. For example, consider a European MedTech company with a CE-marked Class IIa device. They targeted Colombia, assuming a smooth registration process due to the similar classification system. However, they faced a six-month delay because their technical dossier, while compliant in the EU, lacked specific local declarations and formatting required by INVIMA. This small oversight cost them a critical sales season and highlighted the importance of localized expertise. Key questions answered in this episode: - Why isn't there a single classification system for all of Latin America? - What's the crucial difference between Brazil's `Cadastro` and `Registro` pathways? - How can a reference country approval from the FDA help in Mexico, and what is the most common mistake companies make in the process? - Why does Colombia's EU-like system still catch experienced European manufacturers by surprise? - What are the top three documentation details that lead to registration rejection in these key markets? - How do device grouping or family definitions differ between ANVISA, COFEPRIS, and INVIMA? At Pure Global, we specialize in turning these regulatory challenges into market opportunities. Our combination of local experts in over 30 markets and advanced AI-powered data tools ensures your path to registration is clear and efficient. Don't let regulatory details derail your LATAM expansion. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn how we can accelerate your market access.
    続きを読む 一部表示
    3 分
  • From FDA to LATAM: How Pure Global Helps Navigate the COFEPRIS Medical Device Pathway in Mexico for Faster Market Access

    From FDA to LATAM: How Pure Global Helps Navigate the COFEPRIS Medical Device Pathway in Mexico for Faster Market Access
    2025/08/22
    This episode of LATAM MedTech Insights dives deep into the medical device approval process in Mexico, governed by the regulatory body COFEPRIS. We demystify the requirements, from device classification to the critical role of a local registration holder, providing a clear roadmap for international MedTech companies looking to enter this lucrative market. We explore the strategic pathways that can save you valuable time and resources. Discover how leveraging your existing approvals from bodies like the US FDA or Health Canada can dramatically accelerate your journey to market, transforming a potentially lengthy process into a streamlined and predictable one. A US-based scaleup with a novel Class II device faced this exact scenario. Their initial submission was stalled for over a year due to documentation errors and a lack of a clear strategy, costing them valuable time and market opportunity. This episode reveals how leveraging an often-overlooked equivalency pathway could have cut their approval time in half and avoided costly mistakes. Key Takeaways from this episode: 1. What are the four main risk classifications for medical devices in Mexico? 2. How can you use your existing FDA or Health Canada approval to speed up COFEPRIS registration? 3. What is a Mexican Registration Holder (MRH), and why is choosing the right one critical to your business's future? 4. What common documentation mistakes lead to costly delays with COFEPRIS? 5. How does the new "Abbreviated Pathway" coming in 2025 change the game for manufacturers? 6. Is it better to use your distributor as your MRH, or an independent third party? 7. What are the specific post-market surveillance requirements you must meet in Mexico? At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. We act as your local representative in over 30 markets, including Mexico, to get your product approved and maintain compliance. Contact us to learn how we can accelerate your entry into the LATAM market at info@pureglobal.com or visit us at https://pureglobal.com/.
    続きを読む 一部表示
    4 分
  • LATAM MedTech Insights by Pure Global: A Strategic Guide to ANVISA Medical Device Registration in Brazil

    LATAM MedTech Insights by Pure Global: A Strategic Guide to ANVISA Medical Device Registration in Brazil
    2025/08/21
    Brazil's MedTech market is a massive opportunity, but ANVISA's complex and unique regulatory requirements can be a significant barrier for foreign manufacturers. This episode provides a clear, step-by-step guide to navigating the medical device registration process, breaking down everything from initial classification to post-market responsibilities. We uncover the critical decisions and common pitfalls that can delay your market entry by years and cost you millions. Learn the strategic importance of every step, from selecting a local partner to preparing for rigorous facility audits, and discover how to leverage recent regulatory changes to your advantage. **Featured Case:** Imagine spending two years and hundreds of thousands of dollars to get your innovative medical device approved in Brazil, only to realize your distributor legally owns your registration. When you decide to switch to a better partner, you're forced to start the entire lengthy and expensive process all over again. This episode explains how this common and costly trap occurs and provides a clear strategy to avoid it from day one. **Key Questions Answered:** - Why is choosing your Brazil Registration Holder (BRH) the single most critical decision for market access? - What is the difference between a Cadastro and a Registro submission, and which path does your device need to follow? - Can my existing FDA clearance or CE Mark help fast-track my ANVISA application? - What specific preparations are needed to pass the mandatory Brazilian Good Manufacturing Practice (BGMP) audit? - Is it possible for a foreign company to register a device without a physical office in Brazil? - How do you avoid the common pitfall of losing your device registration when you change local distributors? - What are the latest regulatory updates from ANVISA that can accelerate your approval timeline? - Why must all technical documentation be submitted in Brazilian Portuguese, and what's the best way to manage this? At Pure Global, we offer end-to-end regulatory solutions to streamline your global market access. We act as your independent local representative in Brazil and over 30 other markets, ensuring you always maintain full control of your assets. Our team combines local expertise with advanced AI tools to efficiently manage technical dossiers, navigate complex submissions, and monitor regulatory changes. Don’t let regulatory hurdles block your entry into LATAM's most promising market. Contact us today at info@pureglobal.com or visit https://pureglobal.com/ to learn how we can accelerate your path to market.
    続きを読む 一部表示
    8 分
  • Unlocking Brazil's MedTech Market: A Pure Global Deep Dive on ANVISA Medical Device Registration for Your LATAM Strategy

    Unlocking Brazil's MedTech Market: A Pure Global Deep Dive on ANVISA Medical Device Registration for Your LATAM Strategy
    2025/08/19

    Brazil represents the largest MedTech market in Latin America, but its regulatory landscape, governed by the agency ANVISA, is one of the most demanding in the world. This episode breaks down the essential steps and common pitfalls companies face when seeking medical device approval in this complex market. We provide a clear overview of the multi-layered process, from initial facility certification to final product registration.

    We explore the critical requirements that every MedTech manufacturer must meet, including the often-underestimated B-GMP certification, the different registration pathways based on device risk class, and the strategic importance of selecting the right Brazil Registration Holder (BRH). We also share a crucial real-world example: learn about a company that appointed its distributor as its BRH, only to find itself trapped and unable to change commercial partners without losing its hard-won market registration, forcing a complete restart of the entire process.


    This episode's key takeaways:

    - Why is a B-GMP certificate the first, and often biggest, hurdle to clear before even submitting your device dossier?

    - What is the crucial difference between the 'Notificação' and 'Registro' pathways under the new RDC 751/2022 regulation?

    - Why is choosing your Brazil Registration Holder one of the most critical strategic decisions you will make?

    - What common mistake can lead to a complete loss of control over your product's registration in Brazil?

    - How do you prepare a technical dossier that meets ANVISA’s specific and demanding requirements?

    - Do you need additional certifications like INMETRO or ANATEL for your device?

    - How can you avoid years of delays and unexpected costs when entering the Brazilian market?


    Navigating the complexities of the Brazilian market requires local expertise and a robust regulatory strategy. At Pure Global, we offer end-to-end solutions, acting as your local representative and using advanced tools to streamline dossier submissions. Ready to build your LATAM market access strategy? Contact our experts at info@pureglobal.com or visit https://pureglobal.com/.
    続きを読む 一部表示
    3 分